Kaplan Fox Encourages Investors of ZoomInfo Technologies Inc. (NASDAQ: GTM) to Contact the Firm to Learn About Their Legal Rights

ZoomInfo announced it cut 2026 revenue guidance by $62M at the midpoint (from $1.247–$1.267B to $1.185–$1.205B), citing a pause in purchasing decisions tied to “AI and agentic confusion.” The company also flagged restructuring costs of $45M–$60M and plans to lay off 20% of its workforce. After the May 11 results, the stock fell $1.98 (-33%) to $4.06 on May 12. Separately, a class action lawsuit was filed alleging the company misled investors about the reliability of its revenue outlook and AI product growth prospects.

Analysis

The legal headline is the distraction; the real signal is that GTM’s AI repositioning is colliding with customer willingness to pay for a standalone sales-intelligence layer. When buyers can assemble a decent-enough workflow from CRM-native AI, search, and internal agents, the pricing power on seat-based or add-on modules compresses quickly, and that tends to show up first in weaker upsell conversion before it hits top-line growth. The market should treat this as a multiple-risk event, not just a one-off litigation reserve story.

Near term, the stock can remain technically oversold, but the next 1-3 month catalyst is whether management can stabilize net retention and slow the downgrade cycle. If the company has to keep cutting guidance or lean harder on restructuring to defend EBITDA, that usually reads as a demand problem wearing a margin mask. The second-order loser is the broader AI-go-to-market bucket: vendors selling point solutions for prospecting, enrichment, and intent may see buyers delay decisions while they evaluate in-house builds or bundled offerings from larger platforms.

Contrarianly, the class action itself is not the main economic risk; these cases often settle into a manageable cash charge relative to the equity move already taken. What is harder to underwrite is whether the decline in trust becomes a sales-cycle issue with enterprise buyers, which could extend beyond one quarter. Falsifiers are simple: a re-acceleration in new ARR, stabilization in upsell rates, or evidence that AI products are increasing attach rather than substituting for core spend.

The setup is more attractive as a relative-value short than as a fresh standalone short after a 30%+ drawdown. If GTM can’t reclaim lost guidance within one cycle, the equity likely grinds lower as the market applies a lower terminal growth multiple to a business exposed to AI commoditization and longer procurement cycles.

Key Decisions for Investors

• Short GTM on any post-news bounce over the next 1-2 weeks; thesis is not the lawsuit but that the revised demand trajectory likely forces another multiple reset if next-quarter commentary remains weak. Risk/reward improves if shares retrace 10-15% off the first flush.
• Pair trade: short GTM / long MSFT over the next 1-3 months to isolate AI-application substitution risk. If customers keep shifting spend toward bundled CRM/search/agent ecosystems, GTM underperforms while MSFT benefits from platform consolidation.
• If options are liquid, use a GTM put spread into the next earnings window rather than outright short stock. The legal overhang can keep implied volatility elevated, but the real downside catalyst is another guidance cut or softer net retention print.
• Avoid buying the dip until management proves that AI products are expanding wallet share rather than cannibalizing legacy seats; the falsifier is a quarter of sequential improvement in upsell and retention metrics.